- |
Naïve to bDMARDs |
Switch from another pen to SB4 pen |
Switch from syringe to SB4 pen |
Other bDMARD therapy |
Total |
- |
(N=331) |
(N=93) |
(N=59) |
(N=9) |
(N=492) |
Aspect |
n (missing) (%) |
n (missing) (%) |
n (missing) (%) |
n (missing) (%) |
n (missing) (%) |
Ease of execution of the injection (‘simple’ or ‘very simple’) |
296 (89%) |
84 (90%) |
50 (1) (86%) |
9 (100%) |
439 (1) (89%) |
Holding the pre-filled pen (‘simple’ or ‘very simple’) |
294 (6) (90%) |
84 (90%) |
46 (78%) |
8 (89%) |
432 (6) (89%) |
Duration of the injection (‘satisfied’ or ‘very satisfied’) |
271 (1) (82%) |
75 (1) (82%) |
48 (2) (84%) |
8 (89%) |
402 (4) (82%) |
Injection without add. pressing of a button (‘satisfied’ or ‘very satisfied’) |
293 (5) (90%) |
75 (1) (82%) |
48 (1) (83%) |
8 (89%) |
424 (7) (87%) |
Acoustic signal (click) (‘clear’ or ‘very clear’) |
303 (2) (92%) |
82 (88%) |
51 (1) (88%) |
9 (100%) |
445 (3) (91%) |
Indication of completed injection (‘clear’ or ‘very clear’) |
292 (1) (88%) |
78 (84%) |
50 (85%) |
9 (100%) |
429 (1) (87%) |
Surface feeling (‘comfortable’ or ‘very comfortable’) |
259 (2) (79%) |
70 (1) (76%) |
40 (1) (69%) |
6 (67%) |
375 (4) (77%) |
Weight (‘comfortable’ or ‘very comfortable’) |
268 (6) (82%) |
78 (1) (85%) |
42 (3) (75%) |
6 (67%) |
394 (10) (82%) |
Satisfaction in comparison with the previous application system for bDMARDS (‘satisfied’ or ‘very satisfied’) |
NA |
79 (1) (86%) |
52 (1) (90%) |
5 (2) (71%) |
136 (4) (87%)a
|
bDMARD = Biological Disease-Modifying Antirheumatic Drug.
a 331 patients naïve to bDMARDs not included in calculations.